Mechanisms of CD8+ T Cell Apoptosis During Acute and Chronic Viral Infections
Mechanisms of CD8+ T Cell Apoptosis During Acute and Chronic Viral Infections
批准号:
8018876
负责人:
JASON Mitchell GRAYSON
金额:
$37.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2012-02-28
关键词:
AcuteAddressAdoptive TransferAffectAntigensApoptosisApoptoticAutoimmunityBone MarrowCD8B1 geneCell CountCell DeathCellsCessation of lifeChronicClear CellCytolysisDataDeath DomainDefectExposure toFamily memberFlow CytometryGenotypeGoalsHumanImmunohistochemistryImmunotherapyIn VitroInfectionLigandsLiverLungLymphocytic choriomeningitis virusMeasuresMediatingMemoryMolecularMonitorMusMutant Strains MiceMutationOrganOrgan TransplantationPartner in relationshipPathway interactionsProcessProliferatingProteinsPublic HealthReceptor SignalingSourceSpleenStimulusT cell responseT-LymphocyteTransgenic MiceTransgenic OrganismsTumor Necrosis Factor Ligand Superfamily Member 6Tumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaTumor Necrosis FactorsVaccinesViralVirus Diseasesapoptosis in lymphocytesbasecancer therapycell typecytokinegraft vs host diseasein vivolymph nodesmutantpathogenpreventreceptorresearch studyresponseselective expressiontherapy developmenttumor
中文摘要
项目概述:我们的目标是确定控制抗原特异性收缩的分子机制
英文摘要
Project Summary: Our goal is to determine the molecular mechanisms that control contraction of antigenspecific
CD8+ T cell responses following acute and chronic viral infections. At the peak of the response,
effector CD8+ T cells contain low levels of Bcl-2 and are susceptible to Bim-mediated apoptosis. Activated
CD8+ T cells are also susceptible to apoptosis through death receptors such as Fas, Tumor Necrosis Factor
Receptor I (TNFRI) or Tumor necrosis factor Related Apoptosis Ligand-Receptor (TRAIL-R). Single mutation of
either Bim or any one death receptor results in delayed contraction of antigen-specific CD8+ T cells following
acute lymphocytic choriomeningitis virus (LCMV) infection but cell numbers eventually decline. However, loss
of both Bim and Fas, a death receptor, results in a lymph node-specific block in contraction following acute
LCMV infection. The specific hypothesis that is being addressed in this proposal is that the contraction of
antigen-specific CD8+ T cells is controlled by both extrinsic and intrinsic death pathways. Specific Aim 1 will
determine the mechanism by which Fas aids Bim in the contraction of antigen-specific CD8+ T cells in the
lymph nodes following acute LCMV infection. First, we will determine if the defects in lymph node contraction
are T cell autonomous by creating Bim-/-Faslpr/lpr P14 TCR transgenic mice. T cells from these mice will be
adoptively transferred into wildtype mice and contraction will be measured. The cells that express Fas Ligand
in the lymph node during contraction will be determined by flow cytometry and immunohistochemistry. The
importance of expression will be determined by adoptive transfer of mutant P14 transgenic T cells into mice
which selectively express functional Fas Ligand. In Specific Aim 2, we will determine the contribution of death
receptor and Bim-mediated apoptosis in regulating contraction. This will be accomplished by creating Bimdeficient
mice that inducibly express a dominantly interfering FADDdd protein, which blocks death receptor
signaling, in their T cells. The sensitivity to apoptosis following exposure to extrinsic and intrinsic deathinducing
stimuli will be measured in na¿ve and activated CD8+ T cells from Bim-/-rtTA-FADDdd in vitro. To
determine the extent to which loss of all death receptor and Bim-induced apoptosis affects responses in other
organs besides the lymph nodes, double mutant mice will be infected with strains of LCMV that induce acute
and chronic infection and contraction of antigen-specific CD8+ T cells will be measured in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposed Drugs to Inhibit Human T Cells and Autoimmunity
-
批准号:8889627
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2014
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Repurposed Drugs to Inhibit Human T Cells and Autoimmunity
-
批准号:8771735
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2014
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
-
批准号:8648978
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2011
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Redox control of CD8 T cell proliferation, differentiation and death
-
批准号:8240546
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2008
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Redox control of CD8 T cell proliferation, differentiation and death
-
批准号:7556319
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2008
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Redox control of CD8 T cell proliferation, differentiation and death
-
批准号:7783793
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2008
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Redox control of CD8 T cell proliferation, differentiation and death
-
批准号:7464853
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2008
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Redox control of CD8 T cell proliferation, differentiation and death
-
批准号:8034740
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2008
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
-
批准号:6372894
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2001
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
-
批准号:6169102
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2000
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
-
批准号:6012901
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1999
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
Flow Cytometry Shared Resource
-
批准号:10092991
-
项目类别:
-
资助金额:$5.25万
-
财政年份:1997
-
负责人:JASON Mitchell GRAYSON
-
依托单位:
海外基金